Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery
Clinical trial NCT04739709 · COMPLETED
Trial details
- NCT number
- NCT04739709
- Sponsor
- Formosa Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2022-03-17
- Enrollment
- 378
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.